Bipolar disorder risk alleles in adult ADHD patients

Attention‐deficit/hyperactivity disorder (ADHD) has an estimated prevalence of 3–5% in adults. Genome‐wide association (GWA) studies have not been performed in adults with ADHD and studies in children have so far been inconclusive, possibly because of the small sample sizes. Larger GWA studies have been performed on bipolar disorder (BD) and BD symptoms, and several potential risk genes have been reported. ADHD and BD share many clinical features and comorbidity between these two disorders is common. We therefore wanted to examine whether the reported BD genetic variants in CACNA1C, ANK3, MYO5B, TSPAN8 and ZNF804A loci are associated with ADHD or with scores on the Mood Disorder Questionnaire (MDQ), a commonly used screening instrument for bipolar spectrum disorders. We studied 561 adult Norwegian ADHD patients and 711 controls from the general population. No significant associations or trends were found between any of the single nucleotide polymorphisms (SNPs) studied and ADHD [odds ratios (ORs) ≤ 1.05]. However, a weak association was found between rs1344706 in ZNF804A (OR = 1.25; P = 0.05) and MDQ. In conclusion, it seems unlikely that these six SNPs with strong evidence of association in BD GWA studies are shared risk variants between ADHD and BD.

[1]  M. McCarthy.  Genomics, type 2 diabetes, and obesity. , 2010, The New England journal of medicine.

[2]  A. Lundervold,et al.  Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder , 2010, Expert review of neurotherapeutics.

[3]  J. Sweeney,et al.  Emotion processing influences working memory circuits in pediatric bipolar disorder and attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[5]  M. Rietschel,et al.  The CACNA1C risk variant for bipolar disorder influences limbic activity , 2010, Molecular Psychiatry.

[6]  D. Kupfer,et al.  Psychiatric disorders in preschool offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring Study (BIOS). , 2010, The American journal of psychiatry.

[7]  J. Haavik,et al.  Bipolar symptoms in adult attention-deficit/hyperactivity disorder: a cross-sectional study of 510 clinically diagnosed patients and 417 population-based controls. , 2010, The Journal of clinical psychiatry.

[8]  U. Hegerl,et al.  Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? , 2010, Current opinion in psychiatry.

[9]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[10]  John P. Rice,et al.  Genome-wide association study of bipolar disorder in European American and African American individuals , 2009, Molecular Psychiatry.

[11]  Benjamin M. Neale,et al.  Genome-wide association studies in ADHD , 2009, Human Genetics.

[12]  P. Asherson,et al.  Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability , 2009, Expert review of neurotherapeutics.

[13]  N. Craddock,et al.  Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk , 2009, Molecular Psychiatry.

[14]  C. Gillberg,et al.  Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5‐microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[15]  S. Cichon,et al.  Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder , 2008, Molecular Psychiatry.

[16]  C. Spencer,et al.  Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.

[17]  S. Gabriel,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[18]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[19]  S. Cichon,et al.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder , 2008, Molecular Psychiatry.

[20]  K. Taylor,et al.  Genome-Wide Association , 2007, Diabetes.

[21]  A. Wingo,et al.  A systematic review of rates and diagnostic validity of comorbid adult attention-deficit/hyperactivity disorder and bipolar disorder. , 2007, The Journal of clinical psychiatry.

[22]  M. Rietschel,et al.  Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD) , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[23]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[24]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[25]  R. Kessler,et al.  Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. , 2007, The British journal of psychiatry : the journal of mental science.

[26]  R. Kessler.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.

[27]  J. McGough,et al.  Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. , 2005, The American journal of psychiatry.

[28]  Poonam Soni,et al.  Emotional Dysregulation in Adult ADHD and Response to Atomoxetine , 2005, Biological Psychiatry.

[29]  J. Smoller,et al.  Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[30]  Joseph Biederman,et al.  The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.

[31]  P. Bridgman.  Myosin-dependent transport in neurons. , 2004, Journal of neurobiology.

[32]  M. Hemler.  Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. , 2003, Annual review of cell and developmental biology.

[33]  Chadwick M. Hales,et al.  Myosin vb is associated with plasma membrane recycling systems. , 2001, Molecular biology of the cell.

[34]  J. Calabrese,et al.  Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. , 2000, The American journal of psychiatry.

[35]  D. Mennin,et al.  Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  V. Bennett,et al.  AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. , 1995, The Journal of biological chemistry.

[37]  P. Wender,et al.  Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment. , 1981, Archives of general psychiatry.

[38]  R A Ophoff,et al.  Expanding the range of ZNF804A variants conferring risk of psychosis , 2011, Molecular Psychiatry.

[39]  J. Calabrese,et al.  Validity of the mood disorder questionnaire: a general population study. , 2003, The American journal of psychiatry.